Skip to NavigationSkip to content

King & Spalding announce appointment of former FDA official

Published on: 27/04/21

Eva Temkin, a former senior FDA official for therapeutic biologics and biosimilars, has joined King & Spalding in Washington, US, as a partner on the FDA and Life Sciences team.

At the FDA, Temkin served as Acting Director for Policy at the Office of Therapeutic Biologics and Biosimilars from 2019 to 2021. She joined the agency in 2013 and held a variety of roles, including senior regulatory counsel at the Office of Therapeutic Biologics and Biosimilars.

Mark Brown, Chair of King & Spalding’s FDA and Life Sciences team commented: “Eva is uniquely qualified to help clients navigate the complex landscape of the dynamic and evolving therapeutic biologics industry, which is often not well-understood by industry, investors, and other interested parties.”

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches